Ultromics, a health-tech company which applies AI to echocardiography, to earlier detect and better diagnose heart disease, has entered a know-how and clinical research agreement with Mayo Clinic. Underpinned by a determination to drive higher standards of patient care, the collaboration will leverage Mayo’s cardiology expertise and insights and feed real world data into Ultromics’ first product to market, EchoGo Core.
Mayo Clinic is one of the world’s leading centers of cardiology and its extensive cardiac datasets will assist Ultromics in the development of the company’s image analysis product suite. The collaboration will be led by Ross Upton, CEO and founder of Ultromics and Patricia A. Pellikka, M.D. cardiologist and clinical researcher at Mayo Clinic, who this week joined Ultromics’ scientific advisory board. Mayo Clinic will also take an equity stake in the company.
EchoGo Core, cleared by the FDA for use by US physicians in November 2019, applies AI and automates the analysis of echocardiograms, measuring key cardiac parameters to support decision-making with zero variability.
Ad Statistics
Times Displayed: 110014
Times Visited: 6644 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Heart disease is the number one cause of death globally, killing 18m people a year, of whom 17m are under 70 years of age and include young people who die of undiagnosed heart disease (Sudden Cardiac Death) and pregnant women.
Announcing the agreement Ross Upton, said: “Our absolute focus is on increasing the diagnostic accuracy of cardiovascular disease, which will ultimately help transform lives through the development of new diagnostic and predictive solutions.”
About Ultromics
Ultromics is a UK-based health technology firm, focused on bringing the benefits of AI to support clinicians in the diagnosis of cardiovascular disease. Founded in 2017, Ultromics applies artificial intelligence to develop echo-based tools in cardiovascular imaging, by combining deep clinical insight with machine learning and some of the largest echo datasets in the world. The revolutionary platform assists clinicians in their decision-making, without disrupting clinical workflow, to drive diagnostic quality and patient care.
Cardiovascular disease is the number one global killer, causing an estimated 17 million deaths. Ultromics’ mission is to enable earlier detection of cardiovascular disease and improve patient outcomes. For more information about Ultromics visit https://ultromics.com/
About Mayo Clinic
Mayo Clinic is a non-profit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing.
The Mayo Clinic Department of Cardiovascular Medicine is one of the largest and most comprehensive heart practices in the world. It includes more than 240 subspecialized experts trained in congenital heart disease in adults and children, coronary artery disease, hypertrophic cardiomyopathy, heart rhythm disorders, and heart valve diseases.
